Pfizer said it expects a positive decision by the end of May on the inclusion of new paediatric data on labelling in Europe for its cholesterol drug Lipitor after European drug regulators recommended the move.
189347 items (189347 unread) in 47 feeds
World Health Organization
(226 unread)
Media
(146550 unread)
Bird Flu
(3059 unread)
Diabetes
(8426 unread)
Cholesterol
(3564 unread)
Cancer
(15116 unread)
HIV
(7259 unread)
Women
(3814 unread)
Men
(1333 unread)
Pfizer said it expects a positive decision by the end of May on the inclusion of new paediatric data on labelling in Europe for its cholesterol drug Lipitor after European drug regulators recommended the move.